[Burden of influenza virus type B and mismatch with the flu vaccine in Spain].
Identifieur interne : 000170 ( Main/Exploration ); précédent : 000169; suivant : 000171[Burden of influenza virus type B and mismatch with the flu vaccine in Spain].
Auteurs : Jose Ma Eiros-Bouza [Espagne] ; Alberto Pérez-RubioSource :
- Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [ 1988-9518 ] ; 2015.
Descripteurs français
- KwdFr :
- Coûts indirects de la maladie (MeSH), Espagne (épidémiologie), Grippe humaine (immunologie), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Humains (MeSH), Réactions croisées (MeSH), Résultat thérapeutique (MeSH), Saisons (MeSH), Spécificité des anticorps (MeSH), Surveillance de la santé publique (MeSH), Vaccins antigrippaux (immunologie), Virus influenza B (MeSH).
- MESH :
- immunologie : Grippe humaine, Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- épidémiologie : Espagne, Grippe humaine.
- Coûts indirects de la maladie, Humains, Réactions croisées, Résultat thérapeutique, Saisons, Spécificité des anticorps, Surveillance de la santé publique, Virus influenza B.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Antibody Specificity (MeSH), Cost of Illness (MeSH), Cross Reactions (MeSH), Humans (MeSH), Influenza B virus (MeSH), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (prevention & control), Public Health Surveillance (MeSH), Seasons (MeSH), Spain (epidemiology), Treatment Outcome (MeSH).
- MESH :
- chemical , immunology : Influenza Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human.
- immunology : Influenza, Human.
- prevention & control : Influenza, Human.
- Antibody Specificity, Cost of Illness, Cross Reactions, Humans, Influenza B virus, Public Health Surveillance, Seasons, Treatment Outcome.
Abstract
INTRODUCTION
Since the 80s two lineages of type B viruses are co - circulating in the world. Antigenic differences between them are important and it leads to lack of cross-reactivity. The impact on the burden of disease due to influenza B virus, poor foresight in estimating which of the two lineages of B viruses circulate in the season, and the consequent lack of immunity in case of including the wrong strain make that the availability of the quadrivalent vaccine is very useful. The aim of this paper is to analyze the past influenza seasons in Spain to assess the burden of disease, divergence between the vaccine strain and the circulating B and viral characteristics associated with type B in each seasonal epidemic.
MATERIAL AND METHODS
Review of all reports issued by the Influenza Surveillance System in Spain since the 2003-2004 season to 2012-2013.
RESULTS
Over the past influenza seasons, although type A was present mostly, circulation of influenza B virus in each season was observed, even being co - dominant in some of them. In a high number of seasons the divergence between the vaccine strain and the circulating strain lineage has been observed
CONCLUSIONS
The protective effect of influenza vaccine has varied depending on the type / subtype of influenza virus studied. The vaccine effectiveness against influenza infection by influenza B virus has varied greatly depending on the season analyzed.
PubMed: 25690144
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Burden of influenza virus type B and mismatch with the flu vaccine in Spain].</title><author><name sortKey="Eiros Bouza, Jose Ma" sort="Eiros Bouza, Jose Ma" uniqKey="Eiros Bouza J" first="Jose Ma" last="Eiros-Bouza">Jose Ma Eiros-Bouza</name><affiliation wicri:level="2"><nlm:affiliation>Alberto Pérez Rubio. Dirección Médica. Hospital Clínico Universitario de Valladolid. Calle Ramón y Cajal 3, 47001. Valladolid, Spain. albertoprz@gmail.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Alberto Pérez Rubio. Dirección Médica. Hospital Clínico Universitario de Valladolid. Calle Ramón y Cajal 3, 47001. Valladolid</wicri:regionArea><placeName><region nuts="2" type="communauté">Castille-et-León</region></placeName></affiliation></author><author><name sortKey="Perez Rubio, Alberto" sort="Perez Rubio, Alberto" uniqKey="Perez Rubio A" first="Alberto" last="Pérez-Rubio">Alberto Pérez-Rubio</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25690144</idno><idno type="pmid">25690144</idno><idno type="wicri:Area/Main/Corpus">00182</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00182</idno><idno type="wicri:Area/Main/Curation">000182</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000182</idno><idno type="wicri:Area/Main/Exploration">000182</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Burden of influenza virus type B and mismatch with the flu vaccine in Spain].</title><author><name sortKey="Eiros Bouza, Jose Ma" sort="Eiros Bouza, Jose Ma" uniqKey="Eiros Bouza J" first="Jose Ma" last="Eiros-Bouza">Jose Ma Eiros-Bouza</name><affiliation wicri:level="2"><nlm:affiliation>Alberto Pérez Rubio. Dirección Médica. Hospital Clínico Universitario de Valladolid. Calle Ramón y Cajal 3, 47001. Valladolid, Spain. albertoprz@gmail.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Alberto Pérez Rubio. Dirección Médica. Hospital Clínico Universitario de Valladolid. Calle Ramón y Cajal 3, 47001. Valladolid</wicri:regionArea><placeName><region nuts="2" type="communauté">Castille-et-León</region></placeName></affiliation></author><author><name sortKey="Perez Rubio, Alberto" sort="Perez Rubio, Alberto" uniqKey="Perez Rubio A" first="Alberto" last="Pérez-Rubio">Alberto Pérez-Rubio</name></author></analytic><series><title level="j">Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</title><idno type="eISSN">1988-9518</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody Specificity (MeSH)</term><term>Cost of Illness (MeSH)</term><term>Cross Reactions (MeSH)</term><term>Humans (MeSH)</term><term>Influenza B virus (MeSH)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Public Health Surveillance (MeSH)</term><term>Seasons (MeSH)</term><term>Spain (epidemiology)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Coûts indirects de la maladie (MeSH)</term><term>Espagne (épidémiologie)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Réactions croisées (MeSH)</term><term>Résultat thérapeutique (MeSH)</term><term>Saisons (MeSH)</term><term>Spécificité des anticorps (MeSH)</term><term>Surveillance de la santé publique (MeSH)</term><term>Vaccins antigrippaux (immunologie)</term><term>Virus influenza B (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Antibody Specificity</term><term>Cost of Illness</term><term>Cross Reactions</term><term>Humans</term><term>Influenza B virus</term><term>Public Health Surveillance</term><term>Seasons</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Coûts indirects de la maladie</term><term>Humains</term><term>Réactions croisées</term><term>Résultat thérapeutique</term><term>Saisons</term><term>Spécificité des anticorps</term><term>Surveillance de la santé publique</term><term>Virus influenza B</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>Since the 80s two lineages of type B viruses are co - circulating in the world. Antigenic differences between them are important and it leads to lack of cross-reactivity. The impact on the burden of disease due to influenza B virus, poor foresight in estimating which of the two lineages of B viruses circulate in the season, and the consequent lack of immunity in case of including the wrong strain make that the availability of the quadrivalent vaccine is very useful. The aim of this paper is to analyze the past influenza seasons in Spain to assess the burden of disease, divergence between the vaccine strain and the circulating B and viral characteristics associated with type B in each seasonal epidemic.</p></div><div type="abstract" xml:lang="en"><p><b>MATERIAL AND METHODS</b></p><p>Review of all reports issued by the Influenza Surveillance System in Spain since the 2003-2004 season to 2012-2013.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Over the past influenza seasons, although type A was present mostly, circulation of influenza B virus in each season was observed, even being co - dominant in some of them. In a high number of seasons the divergence between the vaccine strain and the circulating strain lineage has been observed</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>The protective effect of influenza vaccine has varied depending on the type / subtype of influenza virus studied. The vaccine effectiveness against influenza infection by influenza B virus has varied greatly depending on the season analyzed.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25690144</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1988-9518</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</Title><ISOAbbreviation>Rev Esp Quimioter</ISOAbbreviation></Journal><ArticleTitle>[Burden of influenza virus type B and mismatch with the flu vaccine in Spain].</ArticleTitle><Pagination><MedlinePgn>39-46</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Since the 80s two lineages of type B viruses are co - circulating in the world. Antigenic differences between them are important and it leads to lack of cross-reactivity. The impact on the burden of disease due to influenza B virus, poor foresight in estimating which of the two lineages of B viruses circulate in the season, and the consequent lack of immunity in case of including the wrong strain make that the availability of the quadrivalent vaccine is very useful. The aim of this paper is to analyze the past influenza seasons in Spain to assess the burden of disease, divergence between the vaccine strain and the circulating B and viral characteristics associated with type B in each seasonal epidemic.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Review of all reports issued by the Influenza Surveillance System in Spain since the 2003-2004 season to 2012-2013.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Over the past influenza seasons, although type A was present mostly, circulation of influenza B virus in each season was observed, even being co - dominant in some of them. In a high number of seasons the divergence between the vaccine strain and the circulating strain lineage has been observed</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The protective effect of influenza vaccine has varied depending on the type / subtype of influenza virus studied. The vaccine effectiveness against influenza infection by influenza B virus has varied greatly depending on the season analyzed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eiros-Bouza</LastName><ForeName>Jose Ma</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Alberto Pérez Rubio. Dirección Médica. Hospital Clínico Universitario de Valladolid. Calle Ramón y Cajal 3, 47001. Valladolid, Spain. albertoprz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez-Rubio</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Impacto del virus gripal tipo B y divergencia con la cepa B incluida en la vacuna antigripal en España.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Quimioter</MedlineTA><NlmUniqueID>9108821</NlmUniqueID><ISSNLinking>0214-3429</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="Y">Influenza B virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062486" MajorTopicYN="N">Public Health Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25690144</ArticleId><ArticleId IdType="pii">eiros</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Castille-et-León</li></region></list><tree><noCountry><name sortKey="Perez Rubio, Alberto" sort="Perez Rubio, Alberto" uniqKey="Perez Rubio A" first="Alberto" last="Pérez-Rubio">Alberto Pérez-Rubio</name></noCountry><country name="Espagne"><region name="Castille-et-León"><name sortKey="Eiros Bouza, Jose Ma" sort="Eiros Bouza, Jose Ma" uniqKey="Eiros Bouza J" first="Jose Ma" last="Eiros-Bouza">Jose Ma Eiros-Bouza</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000170 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000170 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25690144
|texte= [Burden of influenza virus type B and mismatch with the flu vaccine in Spain].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25690144" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |